PURPOSE: To study the relationships among visual and physical function trajectories of aging adults. METHODS: The community-based random sample consists of 2520 adults who were aged 65 to 84 years in 1993 to 1995 and reassessed 2, 6, and 8 years later. Presenting and best-corrected Early Treatment Diabetic Retinopathy Study visual acuity were obtained. Activities of daily living (ADLs) and instrumental ADLs (IADLs) were evaluated through survey instruments. Growth curve models were used to simultaneously estimate health trajectories and obtain associations among the trajectories while controlling for relevant covariates. RESULTS: Best-corrected acuity (logMAR) worsened by an average of 0.013 (∼1 letter) annually. ADL difficulties increased by 0.22 standard deviations (SD) and IADL difficulties increased by 0.28 SD annually. Controlling for demographic and health covariates, visual acuity rates of decline correlated with rates of increase in ADL difficulties (r = 0.15, P = 0.05) and IADL difficulties (r = 0.41, P < 0.001). Acuity loss was significantly related to increases in ADLs for men (b = 0.039, P < 0.01), but not for women (b = 0.001, P > 0.9). The direct effects of acuity loss were strongest for IADLs where a 1-unit decline in acuity (logMAR) was associated with a 0.067 SD increase in IADL difficulties (P < 0.001) at baseline, and a 1-unit acuity decline (logMAR) per year resulted in a 0.10 SD unit increase in the rate of change in IADL difficulties (P < 0.001) per year. CONCLUSIONS: Over time, increases in visual acuity loss were related to increased IADL difficulties in men and women and increases in ADL difficulties for men only. The findings support the importance of maintaining vision in older adults.
PURPOSE: To study the relationships among visual and physical function trajectories of aging adults. METHODS: The community-based random sample consists of 2520 adults who were aged 65 to 84 years in 1993 to 1995 and reassessed 2, 6, and 8 years later. Presenting and best-corrected Early Treatment Diabetic Retinopathy Study visual acuity were obtained. Activities of daily living (ADLs) and instrumental ADLs (IADLs) were evaluated through survey instruments. Growth curve models were used to simultaneously estimate health trajectories and obtain associations among the trajectories while controlling for relevant covariates. RESULTS: Best-corrected acuity (logMAR) worsened by an average of 0.013 (∼1 letter) annually. ADL difficulties increased by 0.22 standard deviations (SD) and IADL difficulties increased by 0.28 SD annually. Controlling for demographic and health covariates, visual acuity rates of decline correlated with rates of increase in ADL difficulties (r = 0.15, P = 0.05) and IADL difficulties (r = 0.41, P < 0.001). Acuity loss was significantly related to increases in ADLs for men (b = 0.039, P < 0.01), but not for women (b = 0.001, P > 0.9). The direct effects of acuity loss were strongest for IADLs where a 1-unit decline in acuity (logMAR) was associated with a 0.067 SD increase in IADL difficulties (P < 0.001) at baseline, and a 1-unit acuity decline (logMAR) per year resulted in a 0.10 SD unit increase in the rate of change in IADL difficulties (P < 0.001) per year. CONCLUSIONS: Over time, increases in visual acuity loss were related to increased IADL difficulties in men and women and increases in ADL difficulties for men only. The findings support the importance of maintaining vision in older adults.
Authors: G S Rubin; K Bandeen-Roche; G H Huang; B Muñoz; O D Schein; L P Fried; S K West Journal: Invest Ophthalmol Vis Sci Date: 2001-01 Impact factor: 4.799
Authors: Jayant M Pinto; David W Kern; Kristen E Wroblewski; Rachel C Chen; L Philip Schumm; Martha K McClintock Journal: J Gerontol B Psychol Sci Soc Sci Date: 2014-11 Impact factor: 4.077
Authors: Peter J Dearborn; Merrill F Elias; Kevin J Sullivan; Cara E Sullivan; Michael A Robbins Journal: J Int Neuropsychol Soc Date: 2018-06-21 Impact factor: 2.892
Authors: D Diane Zheng; Sharon L Christ; Byron L Lam; Stacey L Tannenbaum; Christine L Bokman; Kristopher L Arheart; Laura A McClure; Cristina A Fernandez; David J Lee Journal: Invest Ophthalmol Vis Sci Date: 2014-07-24 Impact factor: 4.799
Authors: Sharon L Christ; D Diane Zheng; Bonnielin K Swenor; Byron L Lam; Sheila K West; Stacey L Tannenbaum; Beatriz E Muñoz; David J Lee Journal: JAMA Ophthalmol Date: 2014-12 Impact factor: 7.389
Authors: D Diane Zheng; Sharon L Christ; Byron L Lam; Daniel J Feaster; Kathryn McCollister; David J Lee Journal: JAMA Ophthalmol Date: 2020-04-01 Impact factor: 7.389
Authors: Cécile Delcourt; Jean-François Korobelnik; Gabriëlle H S Buitendijk; Paul J Foster; Christopher J Hammond; Stefano Piermarocchi; Tunde Peto; Nomdo Jansonius; Alireza Mirshahi; Ruth E Hogg; Lionel Bretillon; Fotis Topouzis; Gabor Deak; Jakob Grauslund; Rebecca Broe; Eric H Souied; Catherine Creuzot-Garcher; José Sahel; Vincent Daien; Terho Lehtimäki; Hans-Werner Hense; Elena Prokofyeva; Konrad Oexle; Jugnoo S Rahi; Phillippa M Cumberland; Steffen Schmitz-Valckenberg; Sascha Fauser; Geir Bertelsen; Carel Hoyng; Arthur Bergen; Rufino Silva; Sebastian Wolf; Andrew Lotery; Usha Chakravarthy; Astrid Fletcher; Caroline C W Klaver Journal: Eur J Epidemiol Date: 2015-12-19 Impact factor: 8.082